Marion McCourt - 01 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Marion McCourt
Issuer symbol
REGN
Transactions as of
01 Feb 2024
Net transactions value
-$258,152
Form type
4
Filing time
02 Feb 2024, 16:02:55 UTC
Previous filing
04 Jan 2024
Next filing
06 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $258,152 -273 -1.8% $945.61 14,789 01 Feb 2024 Direct F1
holding REGN Common Stock 158 01 Feb 2024 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023.